Placebo control group in COVID-19 vaccine trials: context and timing matters.

The article presents the discussion on debate about placebo comparators in COVID-19 vaccine trials. Topics include fundamental guiding principle in the cooperation between the sponsor and local stakeholders with full community partnership and engagement throughout; and adult populations being the main problem of many low and middle-income countries regarding the COVID-19 pandemic.